Market revenue in 2023 | USD 98.8 million |
Market revenue in 2030 | USD 144.1 million |
Growth rate | 5.5% (CAGR from 2023 to 2030) |
Largest segment | Coronary stents |
Fastest growing segment | Accessory Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Intravascular Imaging Catheters and Pressure Guidewires, Coronary Stents, PTCA Balloon Catheters, Accessory Devices |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to interventional cardiology devices market will help companies and investors design strategic landscapes.
Coronary stents was the largest segment with a revenue share of 51.62% in 2023. Horizon Databook has segmented the Mexico interventional cardiology devices market based on intravascular imaging catheters and pressure guidewires, coronary stents, ptca balloon catheters, accessory devices covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of CVDs in Mexico is a significant driver of interventional cardiology devices market. Diseases such as coronary artery disease, hypertension, and heart failure are prevalent in the population, leading to a higher demand for interventional cardiology procedures & devices.
With an increasing incidence of risk factors like obesity, diabetes, and sedentary lifestyle, the burden of CVDs continues to rise, further stimulating market growth. The regulatory framework for interventional cardiology devices market in Mexico plays a crucial role in shaping the industry landscape and influencing market dynamics.
In Mexico, medical devices, including interventional cardiology devices, are regulated by the Federal Commission for Protection against Sanitary Risk (COFEPRIS). COFEPRIS establishes and enforces regulations governing the safety, efficacy, & quality of medical devices to ensure patient safety & public health.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico interventional cardiology devices market , including forecasts for subscribers. This country databook contains high-level insights into Mexico interventional cardiology devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account